| Authors: |
Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. snz@sanger.ac.uk.; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 9NB, UK. snz@sanger.ac.uk., Davies H; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden., Ramakrishna M; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Glodzik D; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Zou X; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Martincorena I; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Alexandrov LB; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA.; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA., Martin S; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Wedge DC; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Van Loo P; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Department of Human Genetics, University of Leuven, B-3000, Leuven, Belgium., Ju YS; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands., Brinkman AB; Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA, Nijmegen, The Netherlands., Morganella S; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK., Aure MR; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway., Lingjærde OC; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway.; Department of Computer Science, University of Oslo, Oslo, Norway., Langerød A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway., Ringnér M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden., Ahn SM; Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea., Boyault S; Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373, Lyon Cedex 08, France., Brock JE; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA., Broeks A; The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands., Butler A; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Desmedt C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000, Brussels, Belgium., Dirix L; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Dronov S; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Fatima A; Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands., Gerstung M; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Hooijer GKJ; Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Jang SJ; Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea., Jones DR; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Kim HY; Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea., King TA; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA., Krishnamurthy S; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas, 77030, USA., Lee HJ; Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea., Lee JY; Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea., Li Y; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., McLaren S; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Menzies A; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Mustonen V; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., O'Meara S; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Pauporté I; Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513, Boulogne-Billancourt, France., Pivot X; University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon, 25000, France., Purdie CA; Pathology Department, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK., Raine K; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Ramakrishnan K; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Rodríguez-González FG; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands., Romieu G; Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands., Simpson PT; The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, 4029, Australia., Shepherd R; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Stebbings L; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Stefansson OA; Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland., Teague J; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Tommasi S; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Treilleux I; Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon Cédex 08, France., Van den Eynden GG; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium., Vermeulen P; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium., Vincent-Salomon A; Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248, Paris Cedex 05, France., Yates L; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Van't Veer L; The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands., Tutt A; Breast Cancer Now Research Unit, King's College London, London, SE1 9RT, UK.; Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, SW3 6JB, UK., Knappskog S; Department of Clinical Science, University of Bergen, 5020, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, 5021, Bergen, Norway., Tan BKT; National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore.; Singapore General Hospital, Outram Road, 169608, Singapore, Singapore., Jonkers J; The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands., Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden., Ueno NT; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas, 77030, USA., Sotiriou C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000, Brussels, Belgium., Viari A; Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330, Montbonnot-Saint Martin, France. Alain.Viari@inria.fr.; Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. Alain.Viari@inria.fr., Futreal PA; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas, 77230, USA., Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Span PN; Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, 6525GA, The Netherlands., Van Laere S; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Lakhani SR; The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, 4029, Australia.; Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia., Eyfjord JE; Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101, Reykjavik, Iceland., Thompson AM; Pathology Department, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas, 77030, USA., Birney E; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK., Stunnenberg HG; Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA, Nijmegen, The Netherlands., van de Vijver MJ; Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA., Kong G; Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea. gkong@hanyang.ac.kr., Thomas G; Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France., Stratton MR; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. mrs@sanger.ac.uk. |
